Drug
D0103 | Procaine
S
N
C
S01HA05 Procaine
[S01HA] Local anesthetics
[S01H] LOCAL ANESTHETICS
[S01] OPHTHALMOLOGICALS
[S] Sensory organs
N01BA52 Procaine, combinations
[N01BA] Esters of aminobenzoic acid
[N01B] ANESTHETICS, LOCAL
[N01] ANESTHETICS
[N] Nervous system
N01BA02 Procaine
[N01BA] Esters of aminobenzoic acid
[N01B] ANESTHETICS, LOCAL
[N01] ANESTHETICS
[N] Nervous system
C05AD05 Procaine
[C05AD] Local anesthetics
[C05A] AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
[C05] VASOPROTECTIVES
[C] Cardiovascular system
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
 |
Warning |
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
P264, P270, P301+P312, P330, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| Organism | Test type | Route | Dose (normalized dose) | Effect | Source |
|---|---|---|---|---|---|
| rat | LD50 | intramuscular | > 2gm/kg (2000mg/kg) | Antibiotics Annual. Vol. 3, Pg. 534, 1955/1956. | |
| mouse | LD50 | intramuscular | > 2gm/kg (2000mg/kg) | Antibiotics Annual. Vol. 3, Pg. 534, 1955/1956. | |
| rat | LD50 | intraperitoneal | 420mg/kg (420mg/kg) | Antibiotics Annual. Vol. 3, Pg. 534, 1955/1956. | |
| mouse | LD50 | oral | > 2gm/kg (2000mg/kg) | Antibiotics Annual. Vol. 3, Pg. 534, 1955/1956. | |
| guinea pig | LD50 | intramuscular | 1194mg/kg (1194mg/kg) | Antibiotics Annual. Vol. 3, Pg. 534, 1955/1956. | |
| rat | LD50 | oral | > 2gm/kg (2000mg/kg) | Antibiotics Annual. Vol. 3, Pg. 534, 1955/1956. | |
| mouse | LD50 | intraperitoneal | 371mg/kg (371mg/kg) | Antibiotics Annual. Vol. 3, Pg. 534, 1955/1956. | |
| guinea pig | LD50 | intraperitoneal | 518mg/kg (518mg/kg) | Antibiotics Annual. Vol. 3, Pg. 534, 1955/1956. | |
| mouse | LDLo | subcutaneous | 4gm/kg (4000mg/kg) | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 55, Pg. 23, 1959. | |
| .beta.-(Diethylamino)ethyl 4-aminobenzoate | .beta.-(Diethylamino)ethyl p-aminobenzoate | .beta.-Diethylaminoethyl 4-aminobenzoate |
| 2-(Diethylamino)ethyl 4-aminobenzoate | 2-(Diethylamino)ethyl p-aminobenzoate | 2-(Diethylamino)ethyl-4-aminobenzoate |
| 2-(N,N-diethylamino)ethyl 4-amino-benzoate | 2-(diethylamino)ethyl 4-aminobenzoate;hydrochloride | 2-(diethylamino)ethyl 4-azanylbenzoate |
| 2-(diethylamino)ethyl 4-azanylbenzoate;hydrochloride | 2-Diethylaminoethyl 4-aminobenzoate | 2-Diethylaminoethyl p-aminobenzoate |
| 2-Diethylaminoethylester kyseliny p-aminobenzoove | 2-Diethylaminoethylester kyseliny p-aminobenzoove [Czech] | 4-14-00-01138 (Beilstein Handbook Reference) |
| 4-Amino-benzoic acid 2-diethylamino-ethyl ester | 4-Amino-benzoic acid-beta-diethylaminoethylester | 4-Aminobenzoesaeure-beta-diethylaminoethylester |
| 4-Aminobenzoic acid 2-diethylaminoethyl ester | 4-Aminobenzoic acid diethylaminoethyl ester | 4-amino-benzoic acid2-diethylamino-ethyl ester |
| 4-aminobenzoic acid 2-(diethylamino)ethyl ester | 4-aminobenzoic acid 2-(diethylamino)ethyl ester;hydrochloride | 4Z8Y51M438 |
| 59-46-1 | A16131 | A19427 |
| A832329 | AB00053531 | AB00053531-09 |
| AB00053531_11 | AB00053531_12 | AB0031355 |
| AE-641/00560024 | AK-50386 | AKOS000115407 |
| API0007241 | ARONIS24492 | AX8149095 |
| Allocaine (Salt/Mix) | Aminocaine (Salt/Mix) | Anticort (TM) |
| Anuject | BBC/658 | BBL005106 |
| BDBM64452 | BENZOIC ACID,4-AMINO,2-DIETHYLAMINOETHYL ESTER PROCAIN BASE | BPBio1_000179 |
| BR-50386 | BRD-K24616672-003-05-2 | BRD-K24616672-003-10-2 |
| BRN 0913480 | BSPBio_000161 | BSPBio_002231 |
| Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester | Benzoic acid, p-amino-, 2-(diethylamino)ethyl ester | Benzoic acid,4-amino-,2-(diethylamino)ethyl ester |
| C07375 | CAS-51-05-8 | CCG-205046 |
| CHEBI:8430 | CHEMBL569 | CS-2647 |
| CTK6E8435 | D08422 | DB00721 |
| DS-1216 | DTXSID7045021 | Diethylaminoethyl p-aminobenzoate |
| DivK1c_000120 | Duracaine | EBD36851 |
| EINECS 200-426-9 | EN300-33930 | Epitope ID:115010 |
| FT-0654843 | Factor H3 | GTPL4291 |
| Gerokit | Gerovital | Gerovital H-3 |
| Gerovital H3 (Salt/Mix) | HSDB 3388 | HTS001398 |
| HY-B0546 | IDI1_000120 | InChI=1/C13H20N2O2/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H |
| Jenacain | Jenacaine | KBio1_000120 |
| KBio2_001318 | KBio2_003886 | KBio2_006454 |
| KBio3_001731 | KBioGR_000975 | KBioSS_001318 |
| KS-00000GZ6 | LS-35778 | Lopac-P-9879 |
| Lopac0_000966 | M-7441 | MCULE-8861116126 |
| MFDFERRIHVXMIY-UHFFFAOYSA-N | MLS001304095 | NCGC00015864-01 |
| NCGC00015864-02 | NCGC00015864-03 | NCGC00015864-04 |
| NCGC00162298-01 | NINDS_000120 | NSC 169497 |
| NSC-169497 | NSC169497 | Neocaine (Salt/Mix) |
| Neotonocaine (Salt/Mix) | Nissocaine | Norocaine |
| Novocain | Novocain (Salt/Mix) | Novocaine |
| Novocaine (Salt/Mix) | P1961 | Prestwick0_000041 |
| Prestwick1_000041 | Prestwick2_000041 | Prestwick3_000041 |
| Procain | Procaina | Procaina [INN-Spanish] |
| Procaine (INN) | Procaine [INN:BAN] | Procaine, base |
| Procainum | Procainum [INN-Latin] | Q423741 |
| SAMPL3, G2 | SBB066226 | SBI-0050939.P004 |
| SC-54112 | SCHEMBL3524 | SMR000718771 |
| SP-01 | SP-01A | SP01 |
| SP01A | SPBio_001331 | SPBio_002082 |
| ST024758 | ST24031565 | STK177303 |
| Scurocaine (Salt/Mix) | Sevicaine (Salt/Mix) | Solution of novocain (TN) |
| Spectrum2_001296 | Spectrum3_000556 | Spectrum4_000488 |
| Spectrum5_001186 | Spectrum_000838 | Spinocaine |
| Stoff H3 | TR-018212 | TR-020622 |
| UNII-4Z8Y51M438 | Vitamin H3 | WLN: ZR DVO2N2&2 |
| X4422 | ZINC1530757 | ZX-AS004859 |
| ZX-AT008592 | aminocaine;anadolor | beta-(Diethylamino)ethyl 4-aminobenzoate |
| beta-(Diethylamino)ethyl p-aminobenzoate | beta-Diethylaminoethyl 4-aminobenzoate | cid_5795 |
| novocaine; | p-Aminobenzoic acid 2-diethylaminoethyl ester | p-Aminobenzoic acid, 2-(diethylamino)ethyl ester |
| p-Aminobenzoyldiethylaminoethanol | procaine | s4668 |
1. Chan et al. (2005)